reserpine has been researched along with norfloxacin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Kaatz, GW; Kerns, RJ; Wei, P | 1 |
| Arpin, C; Ba, BB; Caignard, DH; Forfar-Bares, I; Grellet, J; Guillon, J; Jarry, C; Moreau, S; Quentin, C; Vidaillac, C | 1 |
| Cartier, G; David, B; Dijoux-franca, MG; Gibbons, S; Kaatz, GW; Mariotte, AM; Michalet, S; Stavri, M | 1 |
| Chérigo, L; Fragoso-Serrano, M; Gibbons, S; Jacobo-Herrera, N; Kaatz, GW; Pereda-Miranda, R | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bouillon, A; Cresteil, T; Fontaine, F; Héquet, A; Jolivalt, C; Lesnard, A; Rault, S; Voisin-Chiret, AS | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hooper, DC; Ng, EY; Trucksis, M | 1 |
| Brenwald, NP; Gill, MJ; Wise, R | 1 |
| Kaatz, GW; Seo, SM | 1 |
| Johnson, MM; Marrer, E; Page, MG; Piddock, LJ; Satoh, AT; Schad, K | 1 |
| Aznar, J; Iraurgui, P; Torres, MJ | 1 |
| Cattoir, V; Courvalin, P; Galimand, M; Guérin, F; Tuambilangana, F | 1 |
| Cui, Y; Feng, Z; Liang, Y; Liu, D; Liu, Q; Liu, Z; Wang, Y; Zang, Z | 1 |
1 review(s) available for reserpine and norfloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
16 other study(ies) available for reserpine and norfloxacin
| Article | Year |
|---|---|
Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps.
Topics: Bacterial Proteins; Biological Transport, Active; Drug Resistance, Multiple, Bacterial; Paroxetine; Piperidines; Staphylococcus aureus; Structure-Activity Relationship | 2004 |
Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Indicators and Reagents; Kinetics; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Omeprazole; Staphylococcus aureus; Structure-Activity Relationship | 2007 |
N-caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors.
Topics: Amides; Anti-Bacterial Agents; Bacteria; Caffeic Acids; Cinnamates; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethidium; Membrane Transport Proteins; Microbial Sensitivity Tests; Mirabilis; Norfloxacin; Plant Extracts; Reserpine; Staphylococcus aureus; Structure-Activity Relationship | 2007 |
Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides.
Topics: Anti-Bacterial Agents; Carbohydrate Sequence; Chromatography, High Pressure Liquid; Drug Resistance, Multiple, Bacterial; Fatty Acids; Glycosides; Ipomoea; Membrane Transport Proteins; Mexico; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal; Resins, Plant; Staphylococcus aureus | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Boronic Acids; Ciprofloxacin; Humans; KB Cells; Multidrug Resistance-Associated Proteins; Pyridines; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.
Topics: Amino Acid Sequence; Anti-Infective Agents; Base Sequence; Biological Transport; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Drug Resistance, Microbial; Magnesium; Molecular Sequence Data; Norfloxacin; Reserpine; RNA, Messenger; Staphylococcus aureus; Verapamil | 1994 |
The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Mutation; Norfloxacin; Reserpine; Streptococcus pneumoniae | 1997 |
Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Base Sequence; DNA Topoisomerases, Type I; Drug Resistance, Microbial; Enoxacin; Ethidium; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Norfloxacin; Polymorphism, Restriction Fragment Length; Reserpine; Staphylococcus aureus | 1997 |
Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae.
Topics: Anti-Infective Agents; ATP-Binding Cassette Transporters; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Norfloxacin; Phenotype; Reserpine; RNA, Messenger; Streptococcus pneumoniae | 2006 |
Molecular epidemiology of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae in Seville.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; DNA Gyrase; DNA Mutational Analysis; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Fluoroquinolones; Humans; Infant; Job Syndrome; Levofloxacin; Male; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pneumococcal Infections; Reserpine; Serotyping; Spain; Streptococcus pneumoniae | 2012 |
Overexpression of the novel MATE fluoroquinolone efflux pump FepA in Listeria monocytogenes is driven by inactivation of its local repressor FepR.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Listeria monocytogenes; Norfloxacin; Reserpine | 2014 |
Cloning and Functional Characterization of Putative
Topics: Adenosine Triphosphatases; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cloning, Molecular; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli K12; Escherichia coli Proteins; Genes, MDR; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Reserpine | 2020 |